Arineta is developing a proprietary, novel design CT scanner that is based on a new architecture and optimized for cardiovascular imaging. The Arineta design shall drives out cost by eliminating aspects that are required for whole-body imaging but are irrelevant for cardiac scanning, while optimizing operation for a range of cardiac imaging procedures. The design is covered by granted and pending patents.
The Arineta design goal is a compact high performance imaging system that provides high resolution, motion-free, artifact-free, volumetric images of the whole heart. Arineta will addresses the specific requirements of cardiology procedures and the need for enhanced information during the diagnostic, interventional, and follow-up stages. In addition to imaging of the heart, Arineta is optimizing the design for other cardiovascular studies such as studies of the aorta, the carotid and renal arteries.
The Company’s design is intended to provide a complete solution for cardiac imaging. It will address patient support, integrated ECG and power injector (for delivering contrast agent), image processing and review, display monitors, and accessories. It is intended to be highly integrated into the Cardiology Information System, as well as the image archiving and review systems. In addition to diagnostic imaging, the Arineta scanner will be integrated into the cardiac workflow for therapeutic procedures, providing images for procedure planning, guidance, and navigation.
Note: Arineta does not currently offer any medical devices for sale in the USA or any other country.